Skip to content

Avanos Medical AVNS Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

AMN Healthcare logo
AMN HealthcareAMN
$23.23M+269%
Baxter International logo
Baxter InternationalBAX
-$152M-485%
Scansource logo
ScansourceSCSC
-$79.01M-283%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$65.32M+123%
Globus Medical logo
Globus MedicalGMED
Corvel logo
CorvelCRVL

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's increase (decrease) in accounts receivable?
Avanos Medical (AVNS) reported increase (decrease) in accounts receivable of $300K in Q1 2026.
How has Avanos Medical's increase (decrease) in accounts receivable changed year-over-year?
Avanos Medical's increase (decrease) in accounts receivable increased by 101.2% year-over-year, from -$25.1M to $300K.
What does increase (decrease) in accounts receivable mean?
Tracks the net change in amounts owed to the company by customers for goods or services delivered on credit. An increase typically indicates rising sales or potential collection delays, while a decrease suggests improved cash conversion efficiency.